Life-Sciences-Asia.com
The East-West Life Sciences Web Portal

This is a free web portal for the life sciences in Asia-Pacific, Europe and North America... » read more

Nuclidium Closes CHF79m Series B Financing Round (2025-07-10)
> Proceeds will fund further clinical development of the company’s true theranostic pipeline and expansion of the global production and manufacturing network for copper-based radiopharmaceuticals. > Initial clinical data presented at SNMMI 2025 by Dr. Gary Ula...
Idorsia: Simcere Receives Approval for Quviviq in China (2025-06-23)
Idorsia to receive USD 50 million (an additional USD 30 million) approval milestone payment in return for a reduction in Simcere potential sales milestones and tiered royalty payments. Ad hoc announcement pursuant to Art. 53 LR Idorsia Ltd. (SIX: IDIA) to...
UK NICE Rejects NHS Coverage for Two New Alzheimer Drugs (2025-06-19)
The benefits from donanemab (also called Kisunla and made by Eli Lilly) and lecanemab (also called Leqembi and made by Eisai) - remain too small to justify the additional cost to the NHS, one of our independent committees has concluded following consultation. ...
Sphere Bio Expands Operations in China (2025-06-17)
> Exclusive agreement with specialist biotechnology distributor, Redbert Biotechnology, to strengthen international growth and market penetration. > Johnathan Fu appointed as Country Manager to lead regional partnerships and enhance customer support. [photo...
Arima Genomics Raises $22m Series C; Appoints New CEO (2025-06-17)
llumina Ventures leads round to accelerate Arima’s clinical expansion Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced the appointment of T...
AstraZeneca: up to $5,33b Strategic Collaboration with CSPC (2025-06-13)
AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Limited. Working together on high priority targets, the collaboration aims to advance the discovery and development of novel oral candidates, with the...
BioNTech to Acquire CureVac for $1.25b in Shares (2025-06-12)
> Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy > Acquisition of CureVac will comple...
Deep Apple Therapeutics and Novo Nordisk: up to $812m (2025-06-11)
> Partnership aims to develop first-in-class, small molecule therapeutics directed at a novel non-incretin GPCR target for cardiometabolic diseases > Deep Apple is eligible to receive up to $812 million, including an upfront payment, research costs, and mileston...
Mosanna Therapeutics Launches with $80m Series A Round (2025-06-09)
> Series A funding to advance MOS118 through Phase 2 clinical trials > Biotech veteran David Weber appointed CEO to drive clinical development > Obstructive sleep apnea affects nearly 1 billion people globally, with the majority undiagnosed and underserved wi...
BioNTech & BMS: up to $11.1b for Bispecific Antibody BNT327 (2025-06-02)
> BNT327, BioNTech’s PD-L1xVEGF-A bispecific antibody, is a clinically advanced investigational immunotherapy candidate with the potential to surpass current checkpoint inhibitor outcomes and set a new standard of care in multiple tumor types > The co-developm...

Life-Sciences-Asia.com is your doorway to the East-West life sciences!

[LSA] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Asia-Pacific, Europe and North America regions.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Europe!

» Start here with the latest News!

Picture Consultech GmbH New EU Grants v2 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]